This inventor holds 5 USPTO granted patents. Top assignees: University of Southern California, Other. Active years: 1979-1997.
Location History:
- Los Angeles, CA (US) (1979)
- Glendale, CA (US) (1992 - 1997)
Company Filing History:
3 out of 1,693 
2 out of 834,453 Years Active: 1979-1997
Title: Colin P Spears: Innovator in Cancer Treatment
Introduction
Colin P Spears is a notable inventor based in Glendale, CA (US). He has made significant contributions to the field of cancer treatment, particularly in developing methods to combat drug-resistant tumor cells. With a total of 5 patents, his work has the potential to impact the lives of many patients facing challenging health conditions.
Latest Patents
Among his latest patents is a method of treating drug-resistant tumor cells using organoselenones. This invention focuses on the compound 5,10-methylene-tetrahydrofolate (CH.sub.2 FH.sub.4) and its solution product isomer FH.sub.4. The therapeutic uses of these compounds and their compositions are explored in detail. CH.sub.2 FH.sub.4 and FH.sub.4 have been shown to strongly modulate the in vivo antitumor effects of 5-Fluorouracil, showcasing their potential in enhancing cancer treatment efficacy.
Career Highlights
Colin has worked with the University of Southern California, where he has likely collaborated with other researchers and contributed to various projects. His innovative approaches and research have positioned him as a key figure in the field of oncology.
Collaborations
Colin has collaborated with notable individuals such as Bengt Gustavsson and Sang-Ihn Kang. These partnerships have likely enriched his research and contributed to the development of his patents.
Conclusion
Colin P Spears is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic strategies. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.